Amgen Inc. (NASDAQ:AMGN) saw an upside of 0.64% to $203.18 after adding $1.29 on Wednesday. The 5-day average trading volume is 2,415,355 shares of the company’s common stock. It has gained $212.45 in the past week. An average of 2,631,069 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,600,115.
AMGN’s 1-month performance is -6.84% or -$13.74 on its low of $200.47 reached on 10/12/21. The company’s shares have touched a 52-week low of $200.47 and high of $276.69, with the stock’s rally to the 52-week high happening on 01/28/21. YTD, AMGN has lost -12.19% or -$26.93. However, the current price is down -26.57%% from the 52-week high price.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On May 12, 154 days have gone by since the last insider trading activity for Amgen Inc. (AMGN). SUGAR RONALD D (Director) most recently sold 1,000 shares at $250.59 per share on May 12. This transaction cost the insider $250,590. SVP & CCO, Grygiel Nancy A., sold 2,500 shares at a price of $252.51 on May 11. Then, on May 07, Director Williams R Sanders sold 250 shares at a price of $251.78 per share. This transaction amounted to $62,945.
The company’s PE ratio for the last five years has touched a high of 77.04 and a low of 13.30. AMGN stock has a beta of 0.64. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 4.50 while the price-to-book (PB) in the most recent quarter is 14.03, with the price to cash flow ratio at 22.92.
Amgen Inc. pays an annual dividend of $7.04 per share. Its dividend yield is 3.47% and the payout ratio is 67.90%. AMGN’s most recent quarterly dividend payment was made on Sep. 8, when it paid $1.76 a share compared with prior rate of $1.76, down 0.0% from last year’s. The company has boosted its dividend for the last 10 consecutive years with the latest dividend increase of $0.16 reported on Wednesday December 16 2020. Measured over the last 3 years, the Dividend has been growing by 39.13% yearly.
It is projected that Amgen Inc.’s next ex-dividend date will be on 15-Nov. AMGN is expected to distribute $1.76 as its next dividend.
Amgen Inc.’s quick ratio for the period ended June 29 was 1.00, with the current ratio over the same period at 1.30 meaning that AMGN stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 3.45, while the total debt to equity was 3.98. In terms of profitability, the gross margin trailing 12 months is 75.30%. The trailing 12-month EBITDA margin is 49.76% while for the period ending June 29; Amgen Inc.’s operating margin was 29.10%. The firm’s gross profit as reported stood at $19.27 billion against revenue of $25.42 billion.
For the quarterly period ending June 29 this year, Amgen Inc.’s cash and short-term investments amounted to $1.45 billion against total debt of $32.78 billion. Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected AMGN to announce $4.09 per share in earnings in its latest quarter, but it posted $4.38, representing a 7.10% surprise. EBITDA for the quarter stood at more than $1.68 billion. AMGN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 51.53 billion, with total debt at $32.78 billion. Shareholders hold equity totaling $567.85 million
Let’s look briefly at Amgen Inc. (AMGN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 24.03% to suggest the stock is trending oversold, with historical volatility in this time period at 13.69%.
The stock’s 5-day moving average is $205.93, reflecting a -3.33% or -$6.99 change from its current price. AMGN is currently trading -6.94% above its 20-day SMA, -19.13% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -16.84% and -9.24% respectively.
Stochastic %K and %D was 8.39% and 7.35% and the average true range (ATR) pointed at 3.77. The RSI (14) points at 27.72%, while the 14-day stochastic is at 15.40% with the period’s ATR at 3.78. The stock’s 9-day MACD Oscillator is pointing at -4.68 and -6.38 on the 14-day charts.
In the most recent analyst report for Amgen Inc. (NASDAQ: AMGN), Daiwa Securities downgraded it to a Neutral rating. They previously had an Outperform rating on the stock. Analysts offering their rating for AMGN stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate AMGN as a “sell,”, while 16 advise that investors “Hold.” 2 analysts have rated the stock as underweight. 1 rates the stock as overweight while 7 have offered a “buy” rating.
What is AMGN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $185.00 and a high of $298.00, with their median price target at $244.00. Looking at these predictions, the average price target given by analysts is for Amgen Inc. (AMGN) stock is $245.30.